Taking Derisin for a year is possible to cause Parkinson’s. Derisin, also known as Haloperidol Melitrexed, acts on the nervous system when used to treat symptoms such as depression and anxiety, and may lead to Parkinson’s disease due to its inhibitory effect on dopaminergic neurons.
Derisin, also known as haloperidol melitrexate, is a combination of haloperidol and melitrexate, and its use may lead to neurological adverse effects, extrapyramidal symptoms such as Parkinson’s disease and delayed dyskinesia, as well as other neurological adverse effects such as drowsiness, tremor, and dizziness.
In addition to neurological adverse reactions, the use of Dalisin may also be thrombocytopenia, leukopenia, granulocytopenia, venous embolism, tachycardia, arrhythmia, dry mouth, constipation, nausea, dyspepsia and other systemic adverse reactions.
Delixin can be used for the treatment of mild and moderate depression and anxiety, neurasthenia, psychogenic depression, depressive neurosis, insidious depression, psychosomatic diseases with anxiety and emotional apathy, menopausal depression, alcoholism and drug addiction agitation and depression.
The use of this drug is prohibited in patients with hypersensitivity to melitticin and haloperidol, in patients with circulatory failure, central nervous system depression, in combination with monoamine oxidase preparations.
The drug should be used under the guidance of a specialized physician and in strict accordance with medical advice to avoid adverse consequences.